Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Ester doai
Reexamination Certificate
2008-09-16
2008-09-16
Weddington, Kevin E. (Department: 1614)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Ester doai
C514S909000
Reexamination Certificate
active
11358772
ABSTRACT:
The present invention relates to novel colipase-lipase inhibitors of the general formulae to be used in the treatment of prophylaxis of obesity, as well as pharmaceutical compositions containing the same, and method for treating obesity using said compounds.
REFERENCES:
patent: 4032658 (1977-06-01), Beregi et al.
patent: 4062764 (1977-12-01), White et al.
patent: 4490455 (1984-12-01), Hoffend et al.
patent: 4588843 (1986-05-01), Marlett
patent: 5494894 (1996-02-01), Erlanson-Albertsson
patent: WO98/30588 (1998-07-01), None
Forskarpatent 1 SYD AB
Gauthier & Connors LLP
Weddington Kevin E.
LandOfFree
Lipase-colipase inhibitor does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Lipase-colipase inhibitor, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Lipase-colipase inhibitor will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3917751